CN116602940A - Traditional Chinese medicine emplastrum for improving primary dysmenorrhea and preparation method thereof - Google Patents
Traditional Chinese medicine emplastrum for improving primary dysmenorrhea and preparation method thereof Download PDFInfo
- Publication number
- CN116602940A CN116602940A CN202310285952.1A CN202310285952A CN116602940A CN 116602940 A CN116602940 A CN 116602940A CN 202310285952 A CN202310285952 A CN 202310285952A CN 116602940 A CN116602940 A CN 116602940A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- emplastrum
- primary dysmenorrhea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 58
- 206010013935 Dysmenorrhoea Diseases 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 24
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229940116229 borneol Drugs 0.000 claims abstract description 19
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 19
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 241000218176 Corydalis Species 0.000 claims abstract description 13
- 239000009636 Huang Qi Substances 0.000 claims abstract description 11
- 210000003056 antler Anatomy 0.000 claims abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000000284 extract Substances 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 12
- 241000382455 Angelica sinensis Species 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 238000007873 sieving Methods 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 7
- 238000010992 reflux Methods 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 241000173529 Aconitum napellus Species 0.000 claims description 4
- 229940023019 aconite Drugs 0.000 claims description 4
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 2
- 240000006891 Artemisia vulgaris Species 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 229940126680 traditional chinese medicines Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 17
- 208000002193 Pain Diseases 0.000 abstract description 12
- 208000004998 Abdominal Pain Diseases 0.000 abstract description 10
- 208000024891 symptom Diseases 0.000 abstract description 8
- 239000008280 blood Substances 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 7
- 210000000952 spleen Anatomy 0.000 abstract description 7
- 230000002175 menstrual effect Effects 0.000 abstract description 6
- 210000004185 liver Anatomy 0.000 abstract description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 4
- 210000003734 kidney Anatomy 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 239000004615 ingredient Substances 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 230000007794 irritation Effects 0.000 abstract description 2
- 229940127554 medical product Drugs 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 8
- 108091006146 Channels Proteins 0.000 description 7
- 230000003821 menstrual periods Effects 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 230000005906 menstruation Effects 0.000 description 5
- 239000002674 ointment Substances 0.000 description 3
- 241000282994 Cervidae Species 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 229940107666 astragalus root Drugs 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 241000125175 Angelica Species 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 201000009273 Endometriosis Diseases 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 229940127234 oral contraceptive Drugs 0.000 description 1
- 239000003539 oral contraceptive agent Substances 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
The application relates to the technical field of medical products, in particular to a traditional Chinese medicine emplastrum for improving primary dysmenorrhea and a preparation method thereof. The traditional Chinese medicine emplastrum comprises the following raw materials in parts by weight: 30-40 parts of rhizoma corydalis, 10-15 parts of radix angelicae, 6-10 parts of Chinese angelica, 20-25 parts of antler slice, 15-20 parts of radix astragali preparata, 10-30 parts of caulis sinomenii, 8-10 parts of rhizoma curcumae, 2-5 parts of prepared radix aconiti lateralis preparata, 3-7 parts of folium artemisiae argyi and 4-6 parts of borneol. The ten ingredients of the whole prescription are compatible, the effects of regulating qi and blood, tonifying qi and strengthening spleen, dredging collaterals and relieving pain are achieved by mutual matching, the traditional Chinese medicine emplastrum is adopted, the irritation of oral medicine to gastrointestinal tract is avoided, the toxic and side effects of oral medicine to liver and kidney are avoided, the application range is enlarged, the primary dysmenorrhea can be effectively relieved, the abdominal pain time is shortened, and the menstrual condition and the accompanying symptoms are improved.
Description
Technical Field
The application relates to the technical field of medical products, in particular to a traditional Chinese medicine emplastrum for improving primary dysmenorrhea and a preparation method thereof.
Background
Dysmenorrhea is one of the most common gynecological symptoms, namely pain and distension of the lower abdomen before and after menstruation or during menstrual period, with soreness of waist or other discomfort, and the symptoms seriously affect the quality of life. The genital organs without obvious organic lesions are called primary dysmenorrhea, accounting for more than 90% of dysmenorrhea. Dysmenorrhea is common to teenager women, the incidence rate is high, the incidence rate of dysmenorrhea reported by different research groups is between 30% and 80%, and about three fourths of dysmenorrhea patients can influence normal work and life quality.
At present, pain-relieving sedatives, nonsteroidal anti-inflammatory drugs, oral contraceptives, calcium channel blockers and vitamins are commonly used for treating dysmenorrhea by Western medicine, but the problems of short curative effect, obvious toxic and side effects and the like exist. The traditional Chinese medicine preparation for treating primary dysmenorrhea has various methods, definite curative effect and few side effects, but is an oral preparation, and the traditional Chinese medicine preparation for treating dysmenorrhea mainly adopts addition and subtraction of a menstruation formula, such as four-ingredient soup, a female golden tablet and the like, is mainly administered in an oral mode, and has the characteristics of slower effect, poor taste, difficult wide acceptance and the like, and the oral preparation is easy to stimulate the gastrointestinal tract. Therefore, a traditional Chinese medicine emplastrum with strong drug release permeability for effectively relieving primary dysmenorrhea is urgently needed.
Disclosure of Invention
The first aim of the application is to provide a traditional Chinese medicine emplastrum for improving primary dysmenorrhea and a traditional Chinese medicine emplastrum for improving primary dysmenorrhea, which has strong drug release permeability, can effectively relieve primary dysmenorrhea, shorten abdominal pain time, improve menstruation conditions and accompanying symptoms, and avoid irritation of oral drugs to gastrointestinal tracts.
The second aim of the application is to provide a preparation method of the traditional Chinese medicine emplastrum for improving primary dysmenorrhea.
The application provides a traditional Chinese medicine emplastrum for improving primary dysmenorrhea, which comprises the following raw materials in parts by weight: 30-40 parts of rhizoma corydalis, 10-15 parts of radix angelicae, 6-10 parts of Chinese angelica, 20-25 parts of antler slice, 15-20 parts of radix astragali preparata, 10-30 parts of caulis sinomenii, 8-10 parts of rhizoma curcumae, 2-5 parts of prepared radix aconiti lateralis preparata, 3-7 parts of folium artemisiae argyi and 4-6 parts of borneol.
Preferably, 30-35 parts of rhizoma corydalis, 10-12 parts of radix angelicae, 7-9 parts of angelica sinensis, 20-23 parts of antler slice, 17-20 parts of radix astragali preparata, 15-20 parts of caulis sinomenii, 8-9 parts of rhizoma curcumae, 2-4 parts of prepared aconite, 5-7 parts of folium artemisiae argyi and 4-5 parts of borneol.
Preferably, 33 parts of rhizoma corydalis, 11 parts of radix angelicae, 9 parts of Chinese angelica, 21 parts of antler slice, 19 parts of radix astragali preparata, 16 parts of caulis sinomenii, 8 parts of rhizoma curcumae, 4 parts of prepared accessory slice, 5 parts of folium artemisiae argyi and 5 parts of borneol.
Preferably, the traditional Chinese medicine emplastrum consists of a backing layer, a paste and an anti-sticking layer.
The application also provides a preparation method of the traditional Chinese medicine emplastrum for improving primary dysmenorrhea, which comprises the following steps of:
step one: grinding Borneolum Syntheticum into fine powder, and sieving;
step two: weighing the raw materials of the traditional Chinese medicines, crushing the raw materials into particles, adding 75% ethanol for soaking, heating, refluxing and extracting, and filtering to obtain filtrate;
step three: concentrating the filtrate obtained in the second step into an extract, adding the borneol fine powder obtained in the first step into the extract, and uniformly stirring to obtain a paste for improving primary dysmenorrhea;
step four: and (3) coating the paste obtained in the step (III) on a backing layer, drying, and covering an anti-sticking layer to obtain the traditional Chinese medicine emplastrum for improving primary dysmenorrhea.
Preferably, in the first step, the borneol is sieved by a 200-mesh sieve.
Preferably, the specific steps of the second step are that all Chinese medicinal materials are weighed, crushed into particles, sieved by a 150-mesh sieve, soaked in 5-7 times of 75% ethanol for 2-3 hours, then heated and reflux extracted for 0.5-2 hours, and filtered to obtain filtrate.
Preferably, the relative density of the extract in the third step is 1.06-1.12.
Preferably, the relative density of the extract in the third step is 1.08.
Preferably, in the fourth step, the drying temperature is 30-40 ℃ and the drying time is 9-14h.
The beneficial effects are that:
the corydalis tuber, the angelica and the mugwort leaf in the formula adopted by the application enter liver and spleen channels, warm channels to stop bleeding, dispel cold to stop pain, sooth liver and regulate qi, activate blood to remove meridian obstruction and stop pain as monarch drugs; the deer horn slices have the effects of tonifying kidney yang, replenishing essence and blood, promoting blood circulation and relieving swelling, the roasted astragalus root enters the lung and spleen channels, tonifying qi and tonifying middle-jiao, the caulis sinomenii enters the lung and spleen channels, tonifying qi and tonifying middle-jiao, the prepared accessory slices enter the heart channel, the spleen channel and the kidney channel, return yang and rescue the reverse, tonify fire and invigorate yang, dispel cold and remove dampness, and the deer horn slices, roasted astragalus root, caulis sinomenii and the prepared accessory slices are ministerial drugs, assist monarch drugs in nourishing blood and tonifying qi, dispel cold and remove dampness; the guiding drug is rhizoma zedoariae and radix angelicae, and is used for dispelling wind and eliminating dampness, removing food retention and relieving pain; the borneol is led downwards to promote the absorption of the medicine. Ten ingredients of the whole prescription are compatible, and the effects of regulating qi and blood, tonifying qi and strengthening spleen, dredging collaterals and relieving pain are achieved by mutual matching.
The application adopts the form of Chinese medicine emplastrum, avoids the stimulation of oral medicine to gastrointestinal tract, avoids the toxic and side effects of oral medicine to liver and kidney, expands the application range, and can effectively relieve primary dysmenorrhea, shorten abdominal pain time and improve menstruation condition and accompanying symptoms.
Detailed Description
It should be noted that the following detailed description is illustrative and is intended to provide further explanation of the application. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this application belongs.
It is noted that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of exemplary embodiments according to the present application. As used herein, the singular forms also include the plural unless the context clearly indicates otherwise, and furthermore, it is to be understood that when the terms "comprises" and/or "comprising" are used in this specification, they specify the presence of stated features, steps, operations, devices, components, and/or combinations thereof.
The technical solutions of the present application will be clearly and completely described in connection with the embodiments, and it is apparent that the described embodiments are some embodiments of the present application, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the application without making any inventive effort, are intended to be within the scope of the application.
Example 1
A traditional Chinese medicine emplastrum for improving primary dysmenorrhea comprises the following raw materials in parts by weight: 33 parts of rhizoma corydalis, 11 parts of radix angelicae, 9 parts of Chinese angelica, 21 parts of antler slice, 19 parts of radix astragali preparata, 16 parts of caulis sinomenii, 8 parts of rhizoma curcumae, 4 parts of prepared accessory slice, 5 parts of folium artemisiae argyi and 5 parts of borneol. The Chinese medicinal patch comprises a backing layer, a paste and an anti-sticking layer.
The preparation method comprises the following steps:
step one: grinding Borneolum Syntheticum into fine powder, and sieving with 200 mesh sieve;
step two: weighing the raw materials of each traditional Chinese medicine, crushing into particles, sieving with a 150-mesh sieve, adding 7 times of 75% ethanol for soaking for 3 hours, heating, refluxing and extracting for 1.5 hours, and filtering to obtain filtrate;
step three: concentrating the filtrate obtained in the second step into extract with the relative density of 1.08, adding the borneol fine powder obtained in the first step into the extract, and uniformly stirring to obtain the ointment for improving primary dysmenorrhea;
step four: and (3) coating the paste obtained in the step (III) on a backing layer, drying at 30 ℃ for 14 hours, and covering an anti-sticking layer to obtain the traditional Chinese medicine emplastrum for improving primary dysmenorrhea.
Example 2
A traditional Chinese medicine emplastrum for improving primary dysmenorrhea comprises the following raw materials in parts by weight: 30 parts of rhizoma corydalis, 10 parts of radix angelicae, 10 parts of Chinese angelica, 25 parts of antler slice, 20 parts of radix astragali preparata, 20 parts of caulis sinomenii, 9 parts of rhizoma curcumae, 5 parts of prepared accessory slice, 7 parts of folium artemisiae argyi and 6 parts of borneol. The Chinese medicinal patch comprises a backing layer, a paste and an anti-sticking layer.
The preparation method comprises the following steps:
step one: grinding Borneolum Syntheticum into fine powder, and sieving with 200 mesh sieve;
step two: weighing the raw materials of each traditional Chinese medicine, crushing into particles, sieving with a 150-mesh sieve, adding 6 times of 75% ethanol for soaking for 2.5 hours, heating, refluxing and extracting for 1 hour, and filtering to obtain filtrate;
step three: concentrating the filtrate obtained in the second step into extract with the relative density of 1.12, adding the borneol fine powder obtained in the first step into the extract, and uniformly stirring to obtain the ointment for improving primary dysmenorrhea;
step four: and (3) coating the paste obtained in the step (III) on a backing layer, drying at 35 ℃ for 12 hours, and covering an anti-sticking layer to obtain the traditional Chinese medicine emplastrum for improving primary dysmenorrhea.
Example 3
A traditional Chinese medicine emplastrum for improving primary dysmenorrhea comprises the following raw materials in parts by weight: 40 parts of rhizoma corydalis, 15 parts of radix angelicae, 6 parts of Chinese angelica, 20 parts of antler slice, 15 parts of radix astragali preparata, 10 parts of caulis sinomenii, 10 parts of rhizoma curcumae, 2 parts of prepared accessory slice, 3 parts of folium artemisiae argyi and 4 parts of borneol. The Chinese medicinal patch comprises a backing layer, a paste and an anti-sticking layer.
The preparation method comprises the following steps:
step one: grinding Borneolum Syntheticum into fine powder, and sieving with 200 mesh sieve;
step two: weighing the raw materials of each traditional Chinese medicine, crushing into particles, sieving with a 150-mesh sieve, adding 5 times of 75% ethanol for soaking for 2 hours, heating, refluxing and extracting for 2 hours, and filtering to obtain filtrate;
step three: concentrating the filtrate obtained in the second step into extract with the relative density of 1.06, adding the borneol fine powder obtained in the first step into the extract, and uniformly stirring to obtain the ointment for improving primary dysmenorrhea;
step four: and (3) coating the paste obtained in the step (III) on a backing layer, drying at 40 ℃ for 9 hours, and covering an anti-sticking layer to obtain the traditional Chinese medicine emplastrum for improving primary dysmenorrhea.
Comparative example 1
A traditional Chinese medicine emplastrum for improving primary dysmenorrhea comprises the following raw materials in parts by weight: 40 parts of rhizoma corydalis, 15 parts of herba lycopi, 6 parts of Chinese angelica, 15 parts of radix astragali preparata, 10 parts of caulis sinomenii, 10 parts of rhizoma curcumae, 2 parts of prepared aconite, 3 parts of folium artemisiae argyi and 4 parts of borneol. The Chinese medicinal patch comprises a backing layer, a paste and an anti-sticking layer.
The preparation method is the same as in example 1.
Comparative example 2
A traditional Chinese medicine emplastrum for improving primary dysmenorrhea comprises the following raw materials in parts by weight: 40 parts of rhizoma corydalis, 15 parts of radix angelicae, 6 parts of Chinese angelica, 20 parts of antler slice, 15 parts of honey-fried licorice root, 10 parts of caulis sinomenii, 10 parts of rhizoma curcumae, 2 parts of prepared accessory slice, 3 parts of folium artemisiae argyi and 4 parts of borneol. The Chinese medicinal patch comprises a backing layer, a paste and an anti-sticking layer.
The preparation method is the same as in example 1.
Chinese medicine emplastrum curative effect test
1. Inclusion of case criteria: 600 patients diagnosed with primary dysmenorrhea in a hospital had the following diagnostic symptoms: obvious symptoms such as abdominal pain, abdominal dropsy and the like appear in the period of 1-2 days before menstruation or menstrual period, and secondary dysmenorrhea and early endometriosis are eliminated. Every 100 patients were grouped into six groups.
2. The treatment method comprises the following steps: the Chinese medicinal patch is applied 1 day before menstrual period and on 1 inch half part below umbilicus (three inches below the navel Shen acupoint, the lower abdomen Guanyuan acupoint), and is replaced once daily until menstrual period is completed, and the menstrual period is a course of treatment, and the curative effect is observed after three courses of treatment.
Test group: the traditional Chinese medicine emplastrum prepared in example 1 was used.
Test two groups: the traditional Chinese medicine emplastrum prepared in example 2 was used.
Three groups were tested: the traditional Chinese medicine emplastrum prepared in example 3 was used.
Comparison of one group: the traditional Chinese medicine emplastrum prepared in comparative example 1 was used.
Comparison of two groups: the traditional Chinese medicine emplastrum prepared in comparative example 2 was used.
Blank group: adopts a blank matrix Chinese medicine emplastrum without active ingredients.
3. Therapeutic effect judgment criterion
It is mainly observed in symptoms such as menstrual abdominal pain.
And (3) healing: after 3 treatment courses, the menstrual abdominal pain disappears, and the dysmenorrhea does not appear in the follow-up half year.
The effect is shown: after 3 treatment courses, the menstrual abdominal pain is obviously relieved, or the pain relieving tablet is not needed to be taken for relieving pain during the menstrual period.
The method is effective: for 3 treatment courses, the menstrual abdominal pain is relieved, or the analgesic tablet is taken for a small amount of pain relief during the menstrual period.
Invalidation: after 3 treatment courses, the menstrual abdominal pain is not obviously improved.
4. Test results
The status of the treatment after 3 treatment courses for six groups of patients is shown in table 1.
TABLE 1
Group of | Healing of the wound | Has obvious effect | Effective and effective | Invalidation of | The total effective rate is% |
Test group | 32 | 43 | 15 | 10 | 90 |
Test group II | 27 | 38 | 18 | 17 | 83 |
Test three groups | 30 | 36 | 21 | 13 | 87 |
Contrast group | 19 | 29 | 16 | 36 | 64 |
Comparison of two groups | 23 | 33 | 19 | 25 | 75 |
Blank group | 0 | 0 | 6 | 94 | 6 |
From Table 1, it can be seen that the Chinese medicinal patches prepared in examples 1-3 have far better curative effects than those of comparative examples 1-2 and blank groups, and are effective in regulating qi and blood, invigorating qi and spleen, dredging collaterals and relieving pain, and improving primary dysmenorrhea; the total effective rate of the traditional Chinese medicine emplastrum prepared according to the formula adopted in comparative examples 1-2 is reduced. The traditional Chinese medicine emplastrum prepared in the embodiment 1 has the best effect, the total effective rate is 90 percent, and the traditional Chinese medicine emplastrum has the effects of soothing liver, regulating qi, activating blood and relieving pain and reducing the abdominal pain degree of patients.
Finally, it should be noted that: the above embodiments are only for illustrating the technical solution of the present application, and not for limiting the same; although the application has been described in detail with reference to the foregoing embodiments, it will be understood by those of ordinary skill in the art that: the technical scheme described in the foregoing embodiments can be modified or some or all of the technical features thereof can be replaced by equivalents; such modifications and substitutions do not depart from the spirit of the application.
Claims (10)
1. The traditional Chinese medicine emplastrum for improving primary dysmenorrhea is characterized by comprising the following raw materials in parts by weight: 30-40 parts of rhizoma corydalis, 10-15 parts of radix angelicae, 6-10 parts of Chinese angelica, 20-25 parts of antler slice, 15-20 parts of radix astragali preparata, 10-30 parts of caulis sinomenii, 8-10 parts of rhizoma curcumae, 2-5 parts of prepared radix aconiti lateralis preparata, 3-7 parts of folium artemisiae argyi and 4-6 parts of borneol.
2. The traditional Chinese medicine emplastrum according to claim 1, wherein the traditional Chinese medicine emplastrum is characterized by comprising 30-35 parts of rhizoma corydalis, 10-12 parts of radix angelicae, 7-9 parts of angelica sinensis, 20-23 parts of antler slice, 17-20 parts of radix astragali preparata, 15-20 parts of caulis sinomenii, 8-9 parts of rhizoma curcumae, 2-4 parts of prepared aconite, 5-7 parts of folium artemisiae argyi and 4-5 parts of borneol.
3. The traditional Chinese medicine emplastrum according to claim 1, wherein 33 parts of rhizoma corydalis, 11 parts of radix angelicae, 9 parts of Chinese angelica, 21 parts of antler slice, 19 parts of radix astragali preparata, 16 parts of caulis sinomenii, 8 parts of rhizoma curcumae, 4 parts of prepared aconite, 5 parts of mugwort leaf and 5 parts of borneol.
4. The traditional Chinese medicine patch according to claim 1, wherein the traditional Chinese medicine patch is composed of a backing layer, a paste and an anti-sticking layer.
5. A method for preparing a traditional Chinese medicine emplastrum for improving primary dysmenorrhea as claimed in claims 1 to 4, comprising the following steps:
step one: grinding Borneolum Syntheticum into fine powder, and sieving;
step two: weighing the raw materials of the traditional Chinese medicines, crushing the raw materials into particles, adding 75% ethanol for soaking, heating, refluxing and extracting, and filtering to obtain filtrate;
step three: concentrating the filtrate obtained in the second step into an extract, adding the borneol fine powder obtained in the first step into the extract, and uniformly stirring to obtain a paste for improving primary dysmenorrhea;
step four: and (3) coating the paste obtained in the step (III) on a backing layer, drying, and covering an anti-sticking layer to obtain the traditional Chinese medicine emplastrum for improving primary dysmenorrhea.
6. The process according to claim 5, wherein in the first step, the ice flakes are sieved with a 200-mesh sieve.
7. The preparation method according to claim 5, wherein the specific steps of the second step are that the raw materials of the traditional Chinese medicinal materials are weighed, crushed into particles, sieved by a 150-mesh sieve, soaked in 5-7 times of 75% ethanol for 2-3 hours, heated and refluxed for 0.5-2 hours, and filtered to obtain filtrate.
8. The method according to claim 5, wherein the extract in the third step has a relative density of 1.06-1.12.
9. The method according to claim 8, wherein the extract in step three has a relative density of 1.08.
10. The method according to claim 5, wherein the drying temperature in the fourth step is 30-40℃and the drying time is 9-14 hours.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310285952.1A CN116602940A (en) | 2023-03-22 | 2023-03-22 | Traditional Chinese medicine emplastrum for improving primary dysmenorrhea and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310285952.1A CN116602940A (en) | 2023-03-22 | 2023-03-22 | Traditional Chinese medicine emplastrum for improving primary dysmenorrhea and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116602940A true CN116602940A (en) | 2023-08-18 |
Family
ID=87673505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310285952.1A Pending CN116602940A (en) | 2023-03-22 | 2023-03-22 | Traditional Chinese medicine emplastrum for improving primary dysmenorrhea and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116602940A (en) |
-
2023
- 2023-03-22 CN CN202310285952.1A patent/CN116602940A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101869626A (en) | Chinese medicinal compound preparation private care liquid, and preparation and application thereof | |
CN103877247A (en) | Medicine for treating bedsore and preparation method thereof | |
CN111388618B (en) | Traditional Chinese medicine ointment formula for treating allergic constitution rhinitis and accompanying symptoms thereof and preparation method thereof | |
CN105213557A (en) | A kind of Chinese medicine composition for the treatment of eczema | |
CN1287830C (en) | Chinese traditional medicine compound preparation for treating gynecopathy and preparation method thereof | |
CN105770669A (en) | Medicinal preparation for treating colour spots and application thereof | |
CN104784245A (en) | Medicine for treating cervical cancer | |
CN112402522B (en) | Chinese herbal medicine oil for externally treating psoriasis | |
CN116602940A (en) | Traditional Chinese medicine emplastrum for improving primary dysmenorrhea and preparation method thereof | |
CN104706919B (en) | A kind of pharmaceutical composition for the treatment of ulcer in body surface | |
CN103301373B (en) | Pharmaceutical composition for treating postpartum perineal mucosal lesions | |
CN105343847A (en) | Traditional Chinese medicine composition for treating eczema containing folium artemisiae argyi and preparing method thereof | |
CN114732881B (en) | Traditional Chinese medicine composition and preparation for treating chronic perianal eczema and preparation method thereof | |
CN103301372B (en) | Preparation method of umbilicus dressing agent for treating post-operation prostate stress urinary incontinence | |
CN103330896B (en) | Preparation method of powder for treating postpartum nonspecific vaginitis | |
CN103341108B (en) | Pharmaceutical composite for treating stress urinary incontinence after prostatectomy | |
CN107334941A (en) | A kind of Chinese medicine for treating chronic pelvic inflammatory disease and preparation method thereof | |
CN106421534A (en) | Traditional Chinese medicinal composition for treating rheumatoid arthritis and preparation method thereof | |
CN105687659A (en) | Medicine patch for treating cesarean-postoperative abdominal incision sclerosis | |
CN114632127A (en) | Traditional Chinese medicine composition and preparation for treating pediatric jaundice as well as preparation method and application of traditional Chinese medicine composition and preparation | |
CN105477264A (en) | Medicinal preparation for treating urethral syndrome | |
CN105213732A (en) | A kind of band bed sore ointment and preparation method thereof | |
CN105194469A (en) | Traditional Chinese medicine oral liquid for treating psoriasis and preparation method | |
CN117942383A (en) | Traditional Chinese medicine composition and preparation for treating acute thrombotic external hemorrhoids and preparation method thereof | |
CN104587141A (en) | Gel for treating severe cervical erosion and preparation method of gel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |